We verify your insurance coverage and process necessary prior authorizations
doi: 10.3390/ijms23020739 Summary Keywords metabolic reprogramming, glucagon-like peptide-1 receptor agonists, heart failure, cardiovascular system, diabetes Citation Wang X, Qi M, Yang L, Yang L, Wang X, Zhang F, Cui Y, Wang D, Wang Y and Lv W (2025) GLP-1 receptor agonists synergistic effects of metabolic reprogramming and cardioprotection
[5] Furthermore, the thermic effect of proteinthe energy required to digest and metabolize itis higher (approximately 20-30%) than other macronutrients, potentially supporting metabolic health during weight loss
A structured tapering plan, combined with healthy habits, is essential for maintaining progress after stopping GLP-1 therapy
GLP-1 side effects to monitor for include: Nausea or vomiting Diarrhea or constipation Fatigue Decreased appetite Low blood sugar (hypoglycemia) If any side effects are persistent or concerning to you, contact your prescriber